PetCaseFinder

Peer-reviewed veterinary case report

Cat heart muscle thickening linked to sudden liver infection

By Kim, Byung-Jun et al.·Published in Frontiers in veterinary science·2025·College of Veterinary Medicine, South Korea·View original on PubMed

PetCaseFinder translated the abstract of this peer-reviewed paper into plain English so pet owners can read it. We do not publish original research — every detail traces back to the citation above. How we work →

Original publication title: Case Report: Transient myocardial thickening in a cat secondary to acute cholangiohepatitis.

Species:
cat

Plain-English summary

A 3-year-old Abyssinian cat was brought to the vet with acute cholangiohepatitis, which is a liver infection that can cause jaundice and vomiting. During treatment, the vet noticed that the cat's heart enzyme levels were unusually high, indicating potential heart stress. To help manage both the liver issue and the heart condition, the vet added a medication called atenolol to the treatment plan, which also included antibiotics and other supportive care. After 84 days of follow-up visits, the cat's liver and heart values returned to normal, and the heart's structure improved as well.

People also search for: cat heart problems treatment · cholangiohepatitis in cats · elevated heart enzymes in cats

Abstract

Transient myocardial thickening (TMT) has been reported mainly in young cats following systemic triggers such as anesthesia, surgery, acute stress, or infection; however, to the authors' knowledge, TMT secondary to acute cholangiohepatitis has not been described. A 3-year-old, 5.8-kg castrated male Abyssinian was referred with acute cholangiohepatitis. Initial evaluation revealed increased hepatic enzymes and bilirubin, elevated cardiac troponin I (cTnI, 3.5 ng/mL), and mildly increased N-terminal pro-B-type natriuretic peptide (NT-proBNP, 102.6 pmol/L). On the day of discharge, despite improving hepatic indices, cTnI rose abruptly to 8.0 ng/mL and NT-proBNP exceeded 1,500 pmol/L. Echocardiography demonstrated septal thickening, left atrial enlargement, and systolic anterior motion of the mitral valve, consistent with TMT. Atenolol was added to the outpatient medical management for cholangiohepatitis, consisting of broad-spectrum antimicrobials, hepatoprotectants, and antiemetic/gastroprotective agents. Over the course of 84 days, five follow-up evaluations were performed, during which hepatic values normalized, cTnI and NT-proBNP returned to reference ranges, and myocardial dimensions and vertebral heart score normalized. Unlike most reports in which TMT is identified after congestive signs develop, this case was recognized earlier, on the basis of an abrupt biomarker surge during apparent clinical improvement.

Find similar cases for your pet

PetCaseFinder finds other peer-reviewed reports of pets with the same symptoms, plus a plain-English summary of what was tried across them.

Search related cases →

Original publication on PubMed: https://pubmed.ncbi.nlm.nih.gov/41624289/